;PMID: 3015607
;source_file_1952.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..41] = [t:0..41]
;1)sentence:[e:47..116] = [t:47..116]
;2)section:[e:120..151] = [t:120..151]
;3)sentence:[e:155..305] = [t:155..305]
;4)sentence:[e:307..432] = [t:307..432]
;5)sentence:[e:433..656] = [t:433..656]
;6)sentence:[e:657..773] = [t:657..773]
;7)sentence:[e:774..911] = [t:774..911]
;8)sentence:[e:912..1002] = [t:912..1002]
;9)sentence:[e:1003..1204] = [t:1003..1204]
;10)sentence:[e:1205..1474] = [t:1205..1474]
;11)sentence:[e:1475..1683] = [t:1475..1683]
;12)sentence:[e:1684..1924] = [t:1684..1924]
;13)sentence:[e:1926..2053] = [t:1926..2053]
;14)sentence:[e:2054..2220] = [t:2054..2220]
;15)section:[e:2224..2268] = [t:2224..2268]

;section 0 Span:0..41
;Eur J Biochem. 1986 Jul 1;158(1):195-201.
(SEC
  (FRAG (NNP:[0..3] Eur) (NNP:[4..5] J) (NNP:[6..13] Biochem) (.:[13..14] .)
        (CD:[15..19] 1986) (NNP:[20..23] Jul) (CD:[24..30] 1;158-LRB-)
        (CD:[30..31] 1) (-RRB-:[31..32] -RRB-) (CD:[32..36] :195) (::[36..37] -)
        (CD:[37..40] 201) (.:[40..41] .)))

;sentence 1 Span:47..116
;Mechanisms of lipid peroxidation dependent upon cytochrome P-450 LM2.
;[61..66]:substance:"lipid"
;[95..115]:cyp450:"cytochrome P-450 LM2"
(SENT
  (NP-HLN
    (NP
      (NP (NNS:[47..57] Mechanisms))
      (PP (IN:[58..60] of)
        (NP (NN:[61..66] lipid) (NN:[67..79] peroxidation))))
    (ADJP (JJ:[80..89] dependent)
      (PP (IN:[90..94] upon)
        (NP (NN:[95..105] cytochrome) (NN:[106..111] P-450) (NN:[112..115] LM2))))
    (.:[115..116] .)))

;section 2 Span:120..151
;Ekstrom G, Ingelman-Sundberg M.
(SEC
  (FRAG (NNP:[120..127] Ekstrom) (NNP:[128..129] G) (,:[129..130] ,)
        (NNP:[131..139] Ingelman) (HYPH:[139..140] -) (NNP:[140..148] Sundberg)
        (NNP:[149..151] M.)))

;sentence 3 Span:155..305
;A mechanism of lipid peroxidation dependent on the oxidase activity of 
;cytochrome P-450 LM2 in reconstituted membrane vesicles has been
;investigated.
;[170..175]:substance:"lipid"
;[206..213]:substance:"oxidase"
;[227..247]:cyp450:"cytochrome P-450 LM2"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NP (DT:[155..156] A) (NN:[157..166] mechanism))
        (PP (IN:[167..169] of)
          (NP (NN:[170..175] lipid) (NN:[176..188] peroxidation))))
      (VP (JJ:[189..198] dependent)
        (PP (IN:[199..201] on)
          (NP
            (NP (DT:[202..205] the) (NN:[206..213] oxidase)
                (NN:[214..222] activity))
            (PP (IN:[223..225] of)
              (NP
                (NML (NN:[227..237] cytochrome) (NN:[238..243] P-450))
                (NN:[244..247] LM2)))
            (PP-LOC (IN:[248..250] in)
              (NP (VBN:[251..264] reconstituted) (NN:[265..273] membrane)
                  (NNS:[274..282] vesicles)))))))
    (VP (VBZ:[283..286] has)
      (VP (VBN:[287..291] been)
        (VP (VBN:[292..304] investigated)
          (NP-1 (-NONE-:[304..304] *)))))
    (.:[304..305] .)))

;sentence 4 Span:307..432
;The rate of lipid peroxidation, determined as the formation of 
;thiobarbituric-acid-reactive substances, was inhibited by CO.
;[319..324]:substance:"lipid"
;[371..410]:substance:"thiobarbituric-acid-reactive substances"
;[429..431]:substance:"CO"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NP (DT:[307..310] The) (NN:[311..315] rate))
        (PP (IN:[316..318] of)
          (NP (NN:[319..324] lipid) (NN:[325..337] peroxidation))))
      (,:[337..338] ,)
      (VP (VBN:[339..349] determined)
        (NP (-NONE-:[349..349] *))
        (PP (IN:[350..352] as)
          (NP
            (NP (DT:[353..356] the) (NN:[357..366] formation))
            (PP (IN:[367..369] of)
              (NP
                (ADJP
                  (NML (JJ:[371..385] thiobarbituric) (HYPH:[385..386] -)
                       (NN:[386..390] acid))
                  (HYPH:[390..391] -) (JJ:[391..399] reactive))
                (NNS:[400..410] substances)))))))
    (,:[410..411] ,)
    (VP (VBD:[412..415] was)
      (VP (VBN:[416..425] inhibited)
        (NP-1 (-NONE-:[425..425] *))
        (PP (IN:[426..428] by)
          (NP-LGS (NN:[429..431] CO)))))
    (.:[431..432] .)))

;sentence 5 Span:433..656
;It increased  concomitantly to the production of O-2 and H2O2, when
;cytochrome P-450 LM2 was  incorporated into vesicles containing
;NADPH-cytochrome-P-450 reductase, until a  1:1 molar ratio between the
;enzymes was reached.
;[482..485]:substance:"O-2"
;[490..494]:substance:"H2O2"
;[501..521]:cyp450:"cytochrome P-450 LM2"
;[565..597]:substance:"NADPH-cytochrome-P-450 reductase"
;[608..611]:quantitative-value:"1:1"
;[636..643]:substance:"enzymes"
(SENT
  (S
    (NP-SBJ (PRP:[433..435] It))
    (VP (VBD:[436..445] increased)
      (PP
        (ADVP (RB:[447..460] concomitantly))
        (TO:[461..463] to)
        (NP
          (NP (DT:[464..467] the) (NN:[468..478] production))
          (PP (IN:[479..481] of)
            (NP (NN:[482..485] O-2) (CC:[486..489] and) (NN:[490..494] H2O2)))))
      (,:[494..495] ,)
      (SBAR-ADV
        (WHADVP-3 (WRB:[496..500] when))
        (S
          (NP-SBJ-2
            (NML (NN:[501..511] cytochrome) (NN:[512..517] P-450))
            (NN:[518..521] LM2))
          (VP (VBD:[522..525] was)
            (VP (VBN:[527..539] incorporated)
              (NP-2 (-NONE-:[539..539] *))
              (PP (IN:[540..544] into)
                (NP
                  (NP (NNS:[545..553] vesicles))
                  (VP (VBG:[554..564] containing)
                    (NP
                      (NML
                        (NML (NN:[565..570] NADPH))
                        (HYPH:[570..571] -)
                        (NML (NN:[571..581] cytochrome) (HYPH:[581..582] -)
                             (NN:[582..587] P-450)))
                      (NN:[588..597] reductase)))))
              (ADVP-TMP-3 (-NONE-:[597..597] *T*))))))
      (,:[597..598] ,)
      (SBAR-ADV (IN:[599..604] until)
        (S
          (NP-SBJ-1
            (NP (DT:[605..606] a)
              (NML
                (NML (CD:[608..609] 1))
                (PP (SYM:[609..610] :)
                  (NP (CD:[610..611] 1))))
              (JJ:[612..617] molar) (NN:[618..623] ratio))
            (PP (IN:[624..631] between)
              (NP (DT:[632..635] the) (NNS:[636..643] enzymes))))
          (VP (VBD:[644..647] was)
            (VP (VBN:[648..655] reached)
              (NP-1 (-NONE-:[655..655] *)))))))
    (.:[655..656] .)))

;sentence 6 Span:657..773
;Also the formation of lipid  hydroperoxides was dependent on the presence of
;cytochrome P-450 LM2 in the  membranes.
;[679..700]:substance:"lipid  hydroperoxides"
;[734..754]:cyp450:"cytochrome P-450 LM2"
(SENT
  (S
    (ADVP (RB:[657..661] Also))
    (NP-SBJ
      (NP (DT:[662..665] the) (NN:[666..675] formation))
      (PP (IN:[676..678] of)
        (NP (NN:[679..684] lipid) (NNS:[686..700] hydroperoxides))))
    (VP (VBD:[701..704] was)
      (ADJP-PRD (JJ:[705..714] dependent)
        (PP (IN:[715..717] on)
          (NP
            (NP (DT:[718..721] the) (NN:[722..730] presence))
            (PP (IN:[731..733] of)
              (NP
                (NML (NN:[734..744] cytochrome) (NN:[745..750] P-450))
                (NN:[751..754] LM2)))
            (PP-LOC (IN:[755..757] in)
              (NP (DT:[758..761] the) (NNS:[763..772] membranes)))))))
    (.:[772..773] .)))

;sentence 7 Span:774..911
;This lipid peroxidation was not inhibited by hydroxyl radical  scavengers and
;not specifically inhibited by scavengers of singlet oxygen.
;[779..784]:substance:"lipid"
;[819..847]:substance:"hydroxyl radical  scavengers"
;[882..892]:substance:"scavengers"
;[896..910]:substance:"singlet oxygen"
(SENT
  (S
    (NP-SBJ-1 (DT:[774..778] This) (NN:[779..784] lipid)
              (NN:[785..797] peroxidation))
    (VP (VBD:[798..801] was)
      (VP
        (VP (RB:[802..805] not) (VBN:[806..815] inhibited)
          (NP-1 (-NONE-:[815..815] *))
          (PP (IN:[816..818] by)
            (NP-LGS (NN:[819..827] hydroxyl) (JJ:[828..835] radical)
                    (NNS:[837..847] scavengers))))
        (CC:[848..851] and)
        (VP (RB:[852..855] not)
          (ADVP (RB:[856..868] specifically))
          (VBN:[869..878] inhibited)
          (NP-1 (-NONE-:[878..878] *))
          (PP (IN:[879..881] by)
            (NP-LGS
              (NP (NNS:[882..892] scavengers))
              (PP (IN:[893..895] of)
                (NP (NN:[896..903] singlet) (NN:[904..910] oxygen))))))))
    (.:[910..911] .)))

;sentence 8 Span:912..1002
;By  contrast, superoxide dismutase was a very potent scavenger of the lipid 
;peroxidation.
;[926..946]:substance:"superoxide dismutase"
;[965..974]:substance:"scavenger"
;[982..987]:substance:"lipid"
(SENT
  (S
    (PP (IN:[912..914] By)
      (NP (NN:[916..924] contrast)))
    (,:[924..925] ,)
    (NP-SBJ (NN:[926..936] superoxide) (NN:[937..946] dismutase))
    (VP (VBD:[947..950] was)
      (NP-PRD
        (NP (DT:[951..952] a)
          (ADJP (RB:[953..957] very) (JJ:[958..964] potent))
          (NN:[965..974] scavenger))
        (PP (IN:[975..977] of)
          (NP (DT:[978..981] the) (NN:[982..987] lipid)
              (NN:[989..1001] peroxidation)))))
    (.:[1001..1002] .)))

;sentence 9 Span:1003..1204
;A half-maximal effect at 3 ng/ml enzyme was registered, whereas a  100-fold
;higher concentration was necessary in order to inhibit O-2 formation as 
;detected by succinylated cytochrome c or pyrogallol.
;[1028..1029]:quantitative-value:"3"
;[1030..1042]:quantitative-units:"ng/ml enzyme"
;[1070..1085]:quantitative-value:"100-fold higher"
;[1134..1137]:substance:"O-2"
;[1177..1189]:substance:"cytochrome c"
;[1193..1203]:substance:"pyrogallol"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[1003..1004] A)
        (ADJP (RB:[1005..1009] half) (HYPH:[1009..1010] -)
              (JJ:[1010..1017] maximal))
        (NN:[1018..1024] effect))
      (PP (IN:[1025..1027] at)
        (NP
          (NML
            (NML (CD:[1028..1029] 3) (NN:[1030..1032] ng))
            (PP (SYM:[1032..1033] /)
              (NP (NN:[1033..1035] ml))))
          (NN:[1036..1042] enzyme))))
    (VP (VBD:[1043..1046] was)
      (VP (VBN:[1047..1057] registered)
        (NP-2 (-NONE-:[1057..1057] *))
        (,:[1057..1058] ,)
        (SBAR-ADV (IN:[1059..1066] whereas)
          (S
            (NP-SBJ (DT:[1067..1068] a)
              (ADJP
                (QP (CD:[1070..1073] 100) (HYPH:[1073..1074] -)
                    (RB:[1074..1078] fold))
                (JJR:[1079..1085] higher))
              (NN:[1086..1099] concentration))
            (VP (VBD:[1100..1103] was)
              (ADJP-PRD (JJ:[1104..1113] necessary)
                (SBAR (IN:[1114..1116] in) (NN:[1117..1122] order)
                  (S
                    (NP-SBJ (-NONE-:[1122..1122] *))
                    (VP (TO:[1123..1125] to)
                      (VP (VB:[1126..1133] inhibit)
                        (NP (NN:[1134..1137] O-2) (NN:[1138..1147] formation))
                        (SBAR (IN:[1148..1150] as)
                          (S
                            (NP-SBJ-1 (-NONE-:[1150..1150] *))
                            (VP (VBN:[1152..1160] detected)
                              (NP-1 (-NONE-:[1160..1160] *))
                              (PP-MNR (IN:[1161..1163] by)
                                (NP
                                  (NP (VBN:[1164..1176] succinylated)
                                     (NN:[1177..1187] cytochrome)
                                     (NN:[1188..1189] c))
                                  (CC:[1190..1192] or)
                                  (NP (NN:[1193..1203] pyrogallol)))))))))))))))))
    (.:[1203..1204] .)))

;sentence 10 Span:1205..1474
;The reason for this  difference might be inherent in different types of
;kinetics in the interaction  of O-2 with different scavengers or might
;possibly indicate that SOD scavenges  another type of reactive oxygen,
;different from O-2, generated by cytochrome  P-450 LM2.
;[1309..1312]:substance:"O-2"
;[1328..1338]:substance:"scavengers"
;[1371..1384]:substance:"SOD scavenges"
;[1411..1417]:substance:"oxygen"
;[1434..1437]:substance:"O-2"
;[1452..1473]:cyp450:"cytochrome  P-450 LM2"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1205..1208] The) (NN:[1209..1215] reason))
      (PP (IN:[1216..1219] for)
        (NP (DT:[1220..1224] this) (NN:[1226..1236] difference))))
    (VP
      (VP (MD:[1237..1242] might)
        (VP (VB:[1243..1245] be)
          (ADJP-PRD (JJ:[1246..1254] inherent))
          (PP (IN:[1255..1257] in)
            (NP
              (NP (JJ:[1258..1267] different) (NNS:[1268..1273] types))
              (PP (IN:[1274..1276] of)
                (NP (NNS:[1277..1285] kinetics)))))
          (PP (IN:[1286..1288] in)
            (NP
              (NP (DT:[1289..1292] the) (NN:[1293..1304] interaction))
              (PP (IN:[1306..1308] of)
                (NP (NN:[1309..1312] O-2)))
              (PP (IN:[1313..1317] with)
                (NP (JJ:[1318..1327] different) (NNS:[1328..1338] scavengers)))))))
      (CC:[1339..1341] or)
      (VP (MD:[1342..1347] might)
        (ADVP (RB:[1348..1356] possibly))
        (VP (VB:[1357..1365] indicate)
          (SBAR (IN:[1366..1370] that)
            (S
              (NP-SBJ (NN:[1371..1374] SOD))
              (VP (VBZ:[1375..1384] scavenges)
                (NP
                  (NP (DT:[1386..1393] another) (NN:[1394..1398] type))
                  (PP (IN:[1399..1401] of)
                    (NP
                      (NP
                        (NP (JJ:[1402..1410] reactive) (NN:[1411..1417] oxygen))
                        (,:[1417..1418] ,)
                        (ADJP (JJ:[1419..1428] different)
                          (PP (IN:[1429..1433] from)
                            (NP (NN:[1434..1437] O-2)))))
                      (,:[1437..1438] ,)
                      (VP (VBN:[1439..1448] generated)
                        (NP (-NONE-:[1448..1448] *))
                        (PP (IN:[1449..1451] by)
                          (NP-LGS (NN:[1452..1462] cytochrome)
                                  (NN:[1464..1469] P-450) (NN:[1470..1473] LM2)))))))))))))
    (.:[1473..1474] .)))

;sentence 11 Span:1475..1683
;Iron chelators inhibited the P-450-dependent lipid peroxidation,  whereas
;iron chelate interacted with NADPH-cytochrome-P-450 reductase in the 
;membranes giving rise to reductase-dependent lipid peroxidation.
;[1475..1479]:substance:"Iron"
;[1480..1489]:substance:"chelators"
;[1504..1509]:cyp450:"P-450"
;[1520..1525]:substance:"lipid"
;[1549..1561]:substance:"iron chelate"
;[1578..1610]:substance:"NADPH-cytochrome-P-450 reductase"
;[1644..1653]:substance:"reductase"
;[1664..1669]:substance:"lipid"
(SENT
  (S
    (NP-SBJ (NN:[1475..1479] Iron) (NNS:[1480..1489] chelators))
    (VP (VBD:[1490..1499] inhibited)
      (NP (DT:[1500..1503] the)
        (ADJP (NN:[1504..1509] P-450) (HYPH:[1509..1510] -)
              (JJ:[1510..1519] dependent))
        (NN:[1520..1525] lipid) (NN:[1526..1538] peroxidation))
      (,:[1538..1539] ,)
      (SBAR-ADV (IN:[1541..1548] whereas)
        (S
          (NP-SBJ (NN:[1549..1553] iron) (NN:[1554..1561] chelate))
          (VP (VBD:[1562..1572] interacted)
            (PP-CLR (IN:[1573..1577] with)
              (NP
                (NML
                  (NML (NN:[1578..1583] NADPH))
                  (HYPH:[1583..1584] -)
                  (NML (NN:[1584..1594] cytochrome) (HYPH:[1594..1595] -)
                       (NN:[1595..1600] P-450)))
                (NN:[1601..1610] reductase)))
            (PP-LOC (IN:[1611..1613] in)
              (NP (DT:[1614..1617] the) (NNS:[1619..1628] membranes)))
            (S-ADV
              (NP-SBJ (-NONE-:[1628..1628] *))
              (VP (VBG:[1629..1635] giving)
                (NP (NN:[1636..1640] rise))
                (PP (TO:[1641..1643] to)
                  (NP
                    (ADJP (NN:[1644..1653] reductase) (HYPH:[1653..1654] -)
                          (JJ:[1654..1663] dependent))
                    (NN:[1664..1669] lipid) (NN:[1670..1682] peroxidation)))))))))
    (.:[1682..1683] .)))

;sentence 12 Span:1684..1924
;Neither  superoxide dismutase nor EDTA at high concentrations, inhibited
;CCl4-initiated  lipid peroxidation, indicating the point of action of these
;compounds at the  initiation step in the cytochrome-P-450-LM2-dependent lipid
;peroxidation.
;[1693..1713]:substance:"superoxide dismutase"
;[1718..1722]:substance:"EDTA"
;[1757..1761]:substance:"CCl4"
;[1773..1778]:substance:"lipid"
;[1833..1842]:substance:"compounds"
;[1874..1894]:cyp450:"cytochrome-P-450-LM2"
;[1905..1910]:substance:"lipid"
(SENT
  (S
    (NP-SBJ (CC:[1684..1691] Neither)
      (NP (NN:[1693..1703] superoxide) (NN:[1704..1713] dismutase))
      (CC:[1714..1717] nor)
      (NP
        (NP (NN:[1718..1722] EDTA))
        (PP (IN:[1723..1725] at)
          (NP (JJ:[1726..1730] high) (NNS:[1731..1745] concentrations)))))
    (,:[1745..1746] ,)
    (VP (VBD:[1747..1756] inhibited)
      (NP
        (ADJP (NN:[1757..1761] CCl4) (HYPH:[1761..1762] -)
              (VBN:[1762..1771] initiated))
        (NN:[1773..1778] lipid) (NN:[1779..1791] peroxidation))
      (,:[1791..1792] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1792..1792] *))
        (VP (VBG:[1793..1803] indicating)
          (NP
            (NP (DT:[1804..1807] the) (NN:[1808..1813] point))
            (PP (IN:[1814..1816] of)
              (NP (NN:[1817..1823] action)))
            (PP (IN:[1824..1826] of)
              (NP (DT:[1827..1832] these) (NNS:[1833..1842] compounds))))
          (PP (IN:[1843..1845] at)
            (NP (DT:[1846..1849] the) (NN:[1851..1861] initiation)
                (NN:[1862..1866] step)))
          (PP (IN:[1867..1869] in)
            (NP (DT:[1870..1873] the)
              (ADJP
                (NML
                  (NML (NN:[1874..1884] cytochrome) (HYPH:[1884..1885] -)
                       (NN:[1885..1890] P-450))
                  (HYPH:[1890..1891] -)
                  (NML (NN:[1891..1894] LM2)))
                (HYPH:[1894..1895] -) (JJ:[1895..1904] dependent))
              (NN:[1905..1910] lipid) (NN:[1911..1923] peroxidation))))))
    (.:[1923..1924] .)))

;sentence 13 Span:1926..2053
;Superoxide generated by pyrogallol, in three times the amount produced by
;P-450  LM2, could not bring about lipid peroxidation.
;[1926..1936]:substance:"Superoxide"
;[1950..1960]:substance:"pyrogallol"
;[1965..1976]:quantitative-value:"three times"
;[2000..2010]:cyp450:"P-450  LM2"
;[2034..2039]:substance:"lipid"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1926..1936] Superoxide))
      (VP (VBN:[1937..1946] generated)
        (NP (-NONE-:[1946..1946] *))
        (PP (IN:[1947..1949] by)
          (NP-LGS (NN:[1950..1960] pyrogallol)))))
    (,:[1960..1961] ,)
    (PP (IN:[1962..1964] in)
      (NP
        (NP
          (QP (CD:[1965..1970] three) (NNS:[1971..1976] times))
          (DT:[1977..1980] the) (NN:[1981..1987] amount))
        (VP (VBN:[1988..1996] produced)
          (NP (-NONE-:[1996..1996] *))
          (PP (IN:[1997..1999] by)
            (NP-LGS (NN:[2000..2005] P-450) (NN:[2007..2010] LM2))))))
    (,:[2010..2011] ,)
    (VP (MD:[2012..2017] could) (RB:[2018..2021] not)
      (VP (VB:[2022..2027] bring)
        (PRT (RP:[2028..2033] about))
        (NP (NN:[2034..2039] lipid) (NN:[2040..2052] peroxidation))))
    (.:[2052..2053] .)))

;sentence 14 Span:2054..2220
;It is suggested that the  cytochrome-P-450-dependent lipid peroxidation
;mechanism might be of importance  for intracellular oxidative damage under
;certain conditions.
;[2080..2096]:cyp450:"cytochrome-P-450"
;[2107..2112]:substance:"lipid"
(SENT
  (S
    (NP-SBJ-2
      (NP (PRP:[2054..2056] It))
      (SBAR-1 (-NONE-:[2056..2056] *ICH*)))
    (VP (VBZ:[2057..2059] is)
      (VP (VBN:[2060..2069] suggested)
        (NP-2 (-NONE-:[2069..2069] *))
        (SBAR-1 (IN:[2070..2074] that)
          (S
            (NP-SBJ (DT:[2075..2078] the)
              (ADJP
                (NML (NN:[2080..2090] cytochrome) (HYPH:[2090..2091] -)
                     (NN:[2091..2096] P-450))
                (HYPH:[2096..2097] -) (JJ:[2097..2106] dependent))
              (NN:[2107..2112] lipid) (NN:[2113..2125] peroxidation)
               (NN:[2126..2135] mechanism))
            (VP (MD:[2136..2141] might)
              (VP (VB:[2142..2144] be)
                (PP-PRD (IN:[2145..2147] of)
                  (NP (NN:[2148..2158] importance)))
                (PP (IN:[2160..2163] for)
                  (NP (JJ:[2164..2177] intracellular)
                      (JJ:[2178..2187] oxidative) (NN:[2188..2194] damage)))
                (PP (IN:[2195..2200] under)
                  (NP (JJ:[2201..2208] certain) (NNS:[2209..2219] conditions)))))))))
    (.:[2219..2220] .)))

;section 15 Span:2224..2268
;PMID: 3015607 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2224..2228] PMID) (::[2228..2229] :) (CD:[2230..2237] 3015607)
        (NN:[2238..2239] -LSB-) (NNP:[2239..2245] PubMed) (::[2246..2247] -)
        (NN:[2248..2255] indexed) (IN:[2256..2259] for)
        (NNP:[2260..2268] MEDLINE-RSB-)))
